50 Studies Every Vascular Surgeon Should Know
Series: FIFTY STUDIES EVERY DOCTOR SHOULD SERIES;
- Publisher's listprice GBP 52.00
-
24 843 Ft (23 660 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 484 Ft off)
- Discounted price 22 359 Ft (21 294 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
24 843 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 27 February 2023
- ISBN 9780197637906
- Binding Paperback
- No. of pages296 pages
- Size 156x236x16 mm
- Weight 435 g
- Language English 291
Categories
Short description:
This volume presents the key studies that have shaped the practice of Vascular Surgery, and covers topics including carotid artery disease, aortic aneurysm, peripheral artery disease, trauma, venous disease and vascular access. Each study is concisely summarized, with an emphasis on the results and limitation of the study and its implication for practice. An illustrative clinical case concludes each review to highlight the impact of the study on clinical practice.
MoreLong description:
50 Studies every Vascular Surgeon Should Know presents key studies that have shaped the practice of Vascular Surgery. Selected using a rigorous methodology, the studies cover topics including carotid artery disease, aortic aneurysm, peripheral artery disease, trauma, venous disease and vascular access. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implication for practice.
An illustrative clinical case concludes each review to highlight the impact of the study on clinical practice. This book is a must read for vascular surgeons, especially those in training and preparing for board exams, as well as anyone who wants to learn more about the data behind clinical practice.
Table of Contents:
Section 1: Secondary Prevention in Peripheral Arterial Disease
Julien Al Shakarchi and Andrew Garnham
1. Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE): A Randomized, Blinded Trial
2. Rivaroxaban With or Without Aspirin in Patients with Stable Peripheral or Carotid Artery Disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS), an International, Randomized, Double-Blind, Placebo-Controlled Trial
3. Rivaroxaban in Peripheral Artery Disease After Revascularization (VOYAGER)
4. UK Medical Research Council/British Heart Foundation Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomized Placebo-Controlled Trial
5. Systematic Review of the Efficacy of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication
Section 2: Cerebrovascular Disease
Julien Al Shakarchi and Alok Tiwari
6. Analysis of Pooled Data from the Randomized Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis
7. Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients with Symptomatic Stenosis of the Internal Carotid Artery
8. Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients Without Recent Neurologic Symptoms: First Asymptomatic Carotid Surgery Trial (ACST-1), a Randomized Controlled Trial
9. Safety of Stenting and Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Meta-analysis of Randomized Controlled Trials
10. Second Asymptomatic Carotid Surgery Trial (ACST-2): A Randomized Comparison of Carotid Artery Stenting Versus Carotid Endarterectomy
11. General Anesthesia Versus Local Anesthesia for Carotid Surgery (GALA): A Multicenter, Randomized Controlled Trial
12. Prospective Randomized Trial of Carotid Endarterectomy with Primary Closure and Patch Angioplasty with Saphenous Vein, Jugular Vein, and Polytetrafluoroethylene: Long-Term Follow-up
Section 3: Thoracic Outlet
Julien Al Shakarchi and Andrew Garnham
13. A Decade of Excellent Outcomes After Surgical Intervention in 538 Patients with Thoracic Outlet Syndrome
14. A Systematic Review and Meta-Analysis for the Management of Paget–Schroetter Syndrome
Section 4: Thoracic Aortic Disease
Julien Al Shakarchi and Donald Adam
15. Randomized Comparison of Strategies for Type B Aortic Dissection: The Investigation of Stent Grafts in Aortic Dissection (INSTEAD) Trial
16. Outcomes of 3,309 Thoracoabdominal Aortic Aneurysm Repairs
17. Long-Term Results of Endovascular Repair for Descending Thoracic Aortic Aneurysms
Section 5: Abdominal Aortic Disease
Julien Al Shakarchi
18. Multicenter Aneurysm Screening Study (MASS): Cost-Effectiveness Analysis of Screening for Abdominal Aortic Aneurysms Based on 4-Year Results from a Randomized Controlled Trial
19. Long-Term Outcomes of Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysms: United Kingdom Small Aneurysm Trial (UKSAT)
20. Endovascular Repair Compared with Surveillance for Patients with Small Abdominal Aortic Aneurysms: Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL) Trial
21. Endovascular Versus Open Repair of Abdominal Aortic Aneurysm in 15 Years’ Follow-up of the UK Endovascular Aneurysm Repair Trial 1 (EVAR 1): A Randomized Controlled Trial
22. Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair (EVAR 2)
23. Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (OVER)
24. Endovascular or Open Repair Strategy for Ruptured Abdominal Aortic Aneurysm: 30-Day Outcomes from the Immediate Management of Patients with Rupture: Open Versus Endovascular Repair (IMPROVE) Randomized Trial
25. Meta-analysis of Fenestrated Endovascular Aneurysm Repair Versus Open Surgical Repair of Juxtarenal Abdominal Aortic Aneurysms
Section 6: Visceral and Renal Arterial Disease
Julien Al Shakarchi and Richard Downing
26. Stenting and Medical Therapy for Atherosclerotic Renal Artery Stenosis: The Cardiovascular Outcomes in Renal Atherosclerotic Lesion (CORAL) Trial
27. Patient Survival After Open and Endovascular Mesenteric Revascularization for Chronic Mesenteric Ischemia
28. Splenic Artery Aneurysms: Two Decades of Experience at the Mayo Clinic
29. Renal Artery Aneurysms: A 35-Year Clinical Experience with 252 Aneurysms in 168 Patients
30. Open and Laparoscopic Treatment of Median Arcuate Ligament Syndrome
Section 7: Peripheral Arterial Disease
Julien Al Shakarchi and Lewis Meecham
31. Supervised Exercise Versus Primary Stenting for Claudication Resulting from Aortoiliac Peripheral Artery Disease: The Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study
32. Absence of Long-Term Benefit of Revascularization in Patients with Intermittent Claudication: The Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Study
33. Autologous Saphenous Vein and Expanded Polytetrafluoroethylene Grafts in Infra-inguinal Arterial Reconstructions: A 6-Year Prospective Multicenter Randomized Comparison
34. Bypass Versus Angioplasty in Severe Ischemia of the Leg (BASIL): A Multicenter, Randomized Controlled Trial
35. Is Duplex Surveillance of Value After Leg Vein Bypass Grafting? Principal Results of the Vein Graft Surveillance Randomized Trial (VGST)
36. Dutch Iliac Stent Trial: Long-Term Results in Patients Randomized for Primary or Selective Stent Placement
37. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-analysis of Randomized Controlled Trials
38. Meta-analysis of Open and Endovascular Repair of Popliteal Artery Aneurysms
39. A Prospective Study of Risk Factors for Diabetic Foot Ulcer
Section 8: Venous Disease
Julien Al Shakarchi and Isaac Nyamekye
40. Long-Term Outcome After Additional Catheter-Directed Thrombolysis Versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (the CaVenT Study): A Randomized Controlled Trial
41. Pharmacomechanical Catheter-Directed Thrombolysis for Deep Vein Thrombosis: The Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) Trial
42. Long-Term Results of Compression Therapy Alone Versus Compression Plus Surgery in Chronic Venous Ulceration: The Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) Study, a Randomized Controlled Trial
43. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration: The Early Venous Reflux Ablation (EVRA) Trial
44. 5-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins: The Comparison of Laser, Surgery, and Foam Sclerotherapy (CLASS) Trial
45. Comparison of Endovenous Ablation Techniques, Foam Sclerotherapy, and Surgical Stripping for Great Saphenous Varicose Veins: Extended 5-Year Follow-up of a Randomized Controlled Trial
46. 2-Year Results of a Multicenter Randomized Controlled Trial Comparing Mechanochemical Endovenous Ablation to Radiofrequency Ablation in the Treatment of Primary Great Saphenous Vein Incompetence: The MARADONA Trial
Section 9: Vascular Access
Julien Al Shakarchi and Nicholas Inston
47. Multiple Preoperative and Intraoperative Factors Predict Early Fistula Thrombosis: The Hemodialysis Fistula Maturation (HFM) Study
48. Long-Term Functional Patency and Cost-Effectiveness of Arteriovenous Fistula Creation Under Regional Anesthesia: A Randomized Controlled Trial
Section 10: Trauma
Julien Al Shakarchi and Jack Fairhead
49. Durability of Endovascular Repair in Blunt Traumatic Thoracic Aortic Injury: Long-Term Outcome from Four Tertiary Referral Centers
50. A Multicenter Trial of Vena Cava Filters in Severely Injured Patients
